Phibro Animal Health Corporation (Nasdaq: PAHC) has announced the appointment of Joyce J. Lee, MBA, as a Class II director of ...

Phibro Animal Health (PAHC) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

This appointment is based on a press release statement and reflects Phibro's commitment to enhancing its governance and ...

STERIS’ STE new acquisitions and partnerships strengthen its product offerings. Yet macroeconomic challenges continue to dampen growth. The stock carries a Zacks Rank #3 (Hold) currently. Factors ...

The global Veterinary Vaccines Market, valued at US$8.93 billion in 2023, is forecasted to grow at a robust CAGR of 6.1%, reaching US$9.39 billion in 2024 and an impressive US$13.33 billion by 2029.

Veterinary Pharmaceutical Drug Market Expected To Achieve A Strong 5.07% CAGR, To Reach USD 40.3 Billion By 2032 The rising trend of pet ownership across various regions has significantly impacted the ...

The Global Glycolic Acid Market Size is projected to grow at a CAGR of 5.73% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market was ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Research analysts at Zacks Research raised their Q2 2025 EPS estimates for Phibro Animal Health in a report released on ...